Botox for Neck Bands and the Nefertiti Lift: What It Treats and What It Cannot

The platysma is a wide, thin sheet of muscle running from the upper chest and shoulder area, up across the front of the neck, and attaching along the lower jaw and lower face. It sits just beneath the skin rather than deep among other structures, which is why its movement shows so readily on the surface.

Its fibers do not form one continuous curtain in most people. There is usually a gap toward the midline, and the inner borders on either side of that gap are the edges that become visible. With age and years of repeated contraction those edges thicken and separate from the tissue around them, standing out as vertical cords.

That origin is the most useful thing to understand before you consider treatment. The cords are muscle. They are not folds of loose skin and they are not fat. If you clench your jaw hard and the cords jump out sharply, that is the pattern neurotoxin interrupts.

The platysma also pulls downward as a matter of course. Because it attaches along the jaw, every contraction tugs at the jawline and the corners of the mouth. One anatomical fact therefore explains both treatments here: relax the standing edges and the cords soften, relax the pull along the jaw and the jawline border gets some help.

Patients reach this page from two different search terms and often assume they describe two treatments. Platysmal bands is the clinical name for the visible vertical cords. The Nefertiti lift is a marketing name, borrowed from the sculpted jawline of the Egyptian queen, for a placement pattern aimed at the jawline rather than the cords. Both use the same product in the same muscle.

Treating the bands means placing neurotoxin along the length of the standing cords so those edges stop contracting and settle back toward the surrounding tissue. The goal is a smoother front of the neck, especially in speech and in photographs, where the cords tend to show most.

The Nefertiti pattern concentrates along the upper platysma where it meets the lower border of the jaw. The intent is to reduce the muscle's downward tug so the muscles that lift have slightly less working against them. What people describe is a marginally cleaner jawline border, not a lift in any surgical sense.

The two are frequently planned together, since a patient bothered by cords is usually also bothered by a softening jaw. That combined plan is why a neck quote carries a unit count far larger than anything in the upper face.

This is the most important section on the page, because the neck is where expectations and mechanism part company most often. Neurotoxin acts on muscle contraction and on nothing else. It does not tighten skin, it does not dissolve fat, and it does not reposition tissue that has descended.

Someone whose real concern is crepey, loose skin will not get what they are after from an injection that quiets a muscle. Neither will someone whose main complaint is fullness under the chin. In both cases the treatment can be technically successful and still feel like a disappointment, because it addressed a mechanism that was never the problem.

Sorting this out before you book is worth more than any unit count. Look in the mirror, hold still, and see what remains. Cords that soften or vanish when the neck is completely relaxed are muscular and are the right target. Texture, sag and fullness that sit there unchanged belong to different tools, mapped below.

The neck is treated across a much larger surface than any facial area. Rather than a small knot of muscle between the brows, the injector works along the length of one, two or sometimes several standing bands, and often along the jaw border as well. More territory means more injection points and more product.

Common clinical convention for platysmal bands runs roughly 20 to 60 units of Botox Cosmetic in total, driven by how many bands are present, how thick and long they are, and whether the jawline pattern is added. That total sits well above a glabella or a set of crow's feet, and the gap is anatomical rather than a matter of pricing policy.

This changes the arithmetic of a quote. Under per unit pricing, the neck is a larger number because it is a larger treatment. Under per area pricing, a flat fee can be reasonable or can quietly cap the units included, so ask what the fee actually covers before you agree to it.

Compare quotes by asking which product is being used, how many units the plan calls for, and whether the jawline pattern is included or billed separately. A neck quote and an upper face quote are not comparable numbers, and one that looks unusually low is worth a question rather than a booking.

Onset follows the familiar arc. Movement in the platysma begins softening within roughly three to five days, and the fullest effect lands near ten to fourteen days. Two weeks is the first honest look at what the treatment did, and judging it at day four tells you very little.

Duration here commonly runs toward the shorter end of the usual three to four month expectation, and many patients find the neck fades before upper face areas treated at the same visit. The platysma is broad and superficial, so product is spread across more tissue rather than concentrated into a compact target, and it is recruited constantly through speech, swallowing and head movement.

Injectors are therefore often deliberately conservative here on a first treatment. Underdosing is correctable at a follow up. Overdosing is not correctable at all, since no reversal agent exists for a neuromodulator and the only remedy is waiting for it to wear off.

Expect your interval to settle across two or three cycles. Your injector records what was used and where, then adjusts based on what you report at two weeks and at the point the result began to fade.

The general principle is straightforward. Visible cords paired with reasonably good skin quality respond well. Significant laxity responds poorly, regardless of how prominent the cords look, because relaxing the muscle underneath loose skin does nothing about the skin and can occasionally make the looseness slightly more apparent.

Relax your neck completely and look. Cords that soften substantially at rest and only jump out when you contract are dynamic and muscular, which is the profile that does best. Cords that stand there unchanged alongside thin, crepey skin point to a structural picture a neuromodulator was not built to answer.

Age is a rough proxy rather than a rule. What matters is the ratio of muscle activity to skin laxity, assessed in person and in motion.

Realistic framing helps. Neck neurotoxin is a softening treatment. It reduces the sharpness of cords and takes some downward tension off the jawline, and for the right person that reads as a fresher, calmer neck. It is not a substitute for tightening or surgery, and an injector who says so plainly is telling you something worth hearing.

The neck is a functionally important region. Beneath and around the platysma sit the muscles that manage swallowing and that support and flex the neck, and unlike the upper face there is little margin for product reaching a structure it was not intended for.

Difficulty swallowing and neck weakness are recognized considerations with treatment in this area. They are uncommon, they are associated with excessive dosing or with placement that drifts away from the superficial platysma, and like every neuromodulator effect they are temporary. The point of stating them is not alarm. It is that this area rewards an experienced injector far more than the glabella does.

That should shape how you choose a provider. Ask how often the practice treats platysmal bands specifically, who performs the good faith exam that authorizes the prescription, and who provides medical oversight. Ask what dose is planned and why that number rather than a larger one. An injector who treats the neck regularly answers all of this without hesitation.

Also ask what happens if something feels wrong. Any new difficulty swallowing, weakness in the neck, spreading muscle weakness, or trouble breathing after a neuromodulator treatment warrants prompt medical attention rather than waiting it out. None of this is a reason to avoid the treatment. It is a reason to treat injector selection as the main decision.